Have recently started studying this business. Sharing my analysis here, comments welcome:
Why? – Special Situation investing
- Company has been involved in a legal tussle with Longshen group over one of their JV subsidiaries for ~10 years
- This has led to lack of focus on existing business and material legal costs over the years
- Finally in 2024, the case looks to be headed towards resolution as per Singapore Commercial court by Dec-25
Pros:
- Singapore court case vs Senda (Longsheng group china with 35k Cr Mcap)
- The company has won the case and is entitled to receive the $603 mn by Dec-25. Even with 10% cap gains tax, this is 2.25x the current market cap.
- On 29-Aug, they have also been awarded the legal fee (~2.5 Cr) which is quite low. I am sure they have spent more and are expected to spend 15-20 Cr more till resolution
- Company can get additional ~500 Cr if they win their appeal for interest rate (which wasn’t awarded) on 603 mn (@5.33% per annum for 2 years)
- Dystar valuation:
- Cash on books: $570 mn !!
- Debt: ~0
- Revenue CY23: $735 mn and PAT CY23: $72 mn
- Valuation: Even at a low 9 PE, the valuation should be around $1,220 mn (650+570 mn) or ~10k Cr. A good deal for most PE investors.
- Promoter increasing their stake from 27% to 42% with an infusion of 492 Cr via preferential warrants (can be converted over next 18 months) at 369 (measly 6% discount to CMP) is a sign of their trust in the issue finally being resolved soon. However, few key considerations:
- It doesn’t seem like the promoters have made any initial commitment while obtaining warrants so they might choose to walk away if things don’t materialize as per their expectations.
- They had increased their stake previously in FY18 by 5% (stock went up by 50%) and another 2% in FY19 (stock went up by only 18%) then the stake got reduced to 27% due to FCCB conversion to shares at very low prices
- Existing standalone business
- Revenue (FY24) – 633 Cr and FY 25 (E) – 750 Cr (20% YoY)
- Long-term debt ~24 Cr only
- Guidance: 1200 Cr with 3% EBITDA (highly unlikely)
- Valuation of a languishing business at 0.5x sales multiple = ~350 Cr.
- MD’s remuneration in FY23 was just 1.56 Cr which is not high for a company with 1500 Cr+ mcap and 0 dividends
Cons or Risks:
-
Primary FII investor (Lotus Global Investments Limited) is the same ones as in Hindenburg’s report on Adani. Mysteriously it sold all its stake on 21st Aug at 374. I wonder why when the court looks likely to be resolved.
-
No plan to award existing shareholders with cash from the proceeds
-
Company is planning to venture into unrelated business with new cash. They have ventured into manufacturing of Copper rods, cathodes, copper coils and Fertilizers. Had previously indicated their interest in EV, Renewables, etc
-
Company plans to invest money in 2 phases:
-
Phase-1: 2.4k Cr capex. Expected Sales: 15,000 Cr and Profit – 1.4k-1.5k
-
Phase-2: 6-7k Cr capex. Expected Sales: 25,000 Cr and Profit – 2k
-
Overall revenue (E): 40k Cr with Profit – 3K Cr
-
-
These numbers look a little high to me looking at Hindalco which has ~6% EBITDA margins in their copper vertical. But someone else can guide me here.
- Using Hindalco’s numbers, the profit comes to ~1.5-2k Cr to me. But this is too soon. A lot of execution is left.
-
Expected ROCE : They had previously guided for 25% IRR (internal target is 30%). Looking at other players this seems unlikely. Also, EV slowdown.
Company | ROCE |
---|---|
Hindustan copper | 18% |
Hindalco | 11% |
Bhagyanagar | 21% |
- Standalone business going down the drain and company giving unrealistic guidance of 2x sales and 3% EBITDA margins in Q4FY24 concall, EBITDA was ~0% in Q1FY25.
- They have another JV with Longsheng, Lonsen Kiri, which entails a possibility of another legal tussle in the future. Lonsen Kiri is in fluorine dyes, indigo
Triggers:
- Nov-23: Interest rate and priority settlement appeal
- Apr-25: Sale of Dystar
- Exercise of warrants by promoters
- Entry of big investors. As per management, no big investor has invested because they’re waiting to see if Kiri will receive the money
- Revival of margins and sales in existing standalone business. Some sales has come back in last 2 quarters but nothing to write home about
Subscribe To Our Free Newsletter |